Search research articles
Contact Us
Filters
Showing results (181-190 of 189) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 189 results.
Leukemia
|
June 6, 2017
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia
S Tharkar-Promod, D P Johnson, S E Bennett, et al.
Pathology
|
March 18, 2023
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma
Siba El Hussein, L Jeffrey Medeiros, Kirill A Lyapichev, et al.
Blood
|
March 4, 2024
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor
Warren Fiskus, Jessica Piel, Mike Collins, et al.
Nature Communications
|
May 11, 2021
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
Feng Wang, Kiyomi Morita, Courtney D DiNardo, et al.
Blood Cancer Journal
|
May 21, 2021
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
Warren Fiskus, Christopher P Mill, Behnam Nabet, et al.
Blood Cancer Discovery
|
March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors
Ahmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Patrick K Reville, Xuemei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies
Courtney D DiNardo, Amir T Fathi, Ashwin Kishtagari, et al.
Leukemia
|
August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community
Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 189) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 189 results.
Leukemia
|
June 6, 2017
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia
S Tharkar-Promod, D P Johnson, S E Bennett, et al.
Pathology
|
March 18, 2023
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma
Siba El Hussein, L Jeffrey Medeiros, Kirill A Lyapichev, et al.
Blood
|
March 4, 2024
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor
Warren Fiskus, Jessica Piel, Mike Collins, et al.
Nature Communications
|
May 11, 2021
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
Feng Wang, Kiyomi Morita, Courtney D DiNardo, et al.
Blood Cancer Journal
|
May 21, 2021
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
Warren Fiskus, Christopher P Mill, Behnam Nabet, et al.
Blood Cancer Discovery
|
March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors
Ahmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Tapan M Kadia, Patrick K Reville, Xuemei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies
Courtney D DiNardo, Amir T Fathi, Ashwin Kishtagari, et al.
Leukemia
|
August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community
Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Page
of 19